Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled date : 2021 - 03 - 24 save search
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 15, 2021
Published: 2021-03-24 (Crawled : 21:00) - globenewswire.com
NDAQ | $61.51 0.69% 0.68% 2.8M
|
Finance
|
| O: 0.13%
H: 0.0%
C: -0.64%
positive nasdaq
Touax: 2020 RESULTS Solid operating and financial performance in 2020 and positive outlook for 2021
Published: 2021-03-24 (Crawled : 17:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 1.26%
H: 0.21%
C: -10.41%
positive results
Expectations for the Future of Gold Remain Positive
Published: 2021-03-24 (Crawled : 13:15) - prnewswire.com
KGC | $6.6 0.61% -0.76% 12M
|
Non-Energy Minerals
|
| O: -0.15%
H: 0.37%
C: -1.19%
HL | $5.24 0.0% 6.5M
|
Non-Energy Minerals
|
| O: 2.03%
H: 1.49%
C: -5.14%
FSM | News | $4.64 -0.43% -1.49% 3.7M
|
Non-Energy Minerals
|
| O: 1.2%
H: 0.0%
C: -3.4%
EGO | News | $14.34 -0.76% -0.01% 780K
|
Non-Energy Minerals
|
| O: 1.09%
H: 0.0%
C: -2.87%
RGLD 4 | $120.9 0.41% 0.41% 410K
|
Non-Energy Minerals
|
| O: 0.38%
H: 0.65%
C: -1.36%
positive
Lexaria Technology Generates Positive Stability Testing for World-Class Ready-to-Drink CBD Beverages
Published: 2021-03-24 (Crawled : 12:00) - biospace.com/
LEXX | $2.18 -2.68% -2.75% 98K
|
Health Technology
|
| O: 5.02%
H: 4.19%
C: -5.49%
test positive technology
ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials
Published: 2021-03-24 (Crawled : 12:00) - globenewswire.com
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 7.22%
H: 5.87%
C: -1.9%
positive results positive results trial syndros
Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors
Published: 2021-03-24 (Crawled : 12:00) - globenewswire.com
THTX | $1.29 -12.78% 8.1K
|
Health Technology
|
| O: 0.84%
H: 2.5%
C: -3.61%
solid tumors phase 1 positive trial phase 3 phase 2
BrainStorm Announces Positive Topline Data in Phase 2 Study Evaluating NurOwn® as a Treatment for Progressive MS
Published: 2021-03-24 (Crawled : 12:00) - biospace.com/
BCLI A | $0.5339 1.7% 1.67% 190K
|
Health Technology
|
| O: 18.62%
H: 2.15%
C: -13.12%
treatment phase 2 positive topline
Myovant Sciences and Pfizer Announce Positive Data from Phase 3 LIBERTY Randomized Withdrawal Study of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
Published: 2021-03-24 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.34%
H: 1.27%
C: 0.37%
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 0.3%
H: 1.17%
C: -7.12%
positive therapy women phase 3
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.